Market Research ReportDec 2, 2022

Primary Cells Market

Primary Cells Market Research Report: Size, Share, Trend Analysis Type (Human Primary Cells, Animal Primary Cells), Source (Hematopoietic Cells, Skin Cells, Gastrointestinal Cells, Liver Cells, Lung Cells, Skeletal and Muscle Cells), End User (Pharmaceutical and Biotechnology Companies, Research Institutes) and By Region (Middle East and Africa, North America, Asia Pacific, Europe, South America) - Growth Outlook & Industry Forecast To 2025

Vertical: HealthcareBase Year: 2018

Book Demo

Executive Summary

Primary Cells Market — Snapshot

Market Size (2018)
$722.62M
Projected (2025)
$1.23B
CAGR (2016–2025)
8.1%
Key Players
10+

Primary human cells are isolated directly from normal human tissue or blood cells via the enzymatic or mechanical methods. Primary cells retain their fundamental cellular functions. Hence, their use in cell-based research programs is increasing significantly.

The key factors driving the market growth are growing cancer research across the world, a wide range of applications of primary cells for disease treatment, advantages of primary human cells over cell lines, and growing research and development in biotechnology and biopharmaceutical industries. However, factors such as high cost of advanced primary cells and risk of contamination of primary cells hamper the market growth. The increasing demand for primary cells for research, innovation, and launch of new drugs act as an opportunity for the market.

Key Insight

The Primary Cells Market market is projected to grow at a CAGR of 8.1% from 2016 to 2025.

Market Performance Trend

Historical performance and future projections (2020–2030, USD Billion)

Subscribe to Wantstats

Unlock premium reports, insights, blogs, charts and more.

View Subscription Plans

Market Scope & Coverage

What this report covers

Geographic Coverage: This analysis covers 5 regions: Middle East and Africa, North America, Asia Pacific, Europe, South America.
Market Segmentation: The market is analyzed across 2 segments: Human Primary Cells, Animal Primary Cells. Forecasts are provided for each segment from 2016 to 2025.
Competitive Landscape: 10 leading companies are profiled, covering market positioning, strategies, and recent developments.

Market Size (USD Mn)

Subscribe to Wantstats

Unlock premium reports, insights, blogs, charts and more.

View Subscription Plans

Market Overview

Primary Cells Market — Growth Trajectory

The scope of the global primary cells market study includes the market size analysis and a detailed analysis of the manufacturer’s products and strategies. The market has been segmented based on source, type, end user, and region.

Primary Cells Market — Growth Trajectory

Human Primary Cells

Animal Primary Cells

Subscribe to Wantstats

Unlock premium reports, insights, blogs, charts and more.

View Subscription Plans

Market Size Trend (USD Mn)

Subscribe to Wantstats

Unlock premium reports, insights, blogs, charts and more.

View Subscription Plans

Market Dimensions

How this market is segmented

Type is analyzed as a distinct market dimension.
Source is analyzed as a distinct market dimension.
End User is analyzed as a distinct market dimension.

Geographic Analysis

Regional market breakdown

Middle East and Africa market size reached $34.18M in 2016 and is projected to reach $59.24M by 2025, growing at a CAGR of 6.3%.
North America market size reached $189.72M in 2016 and is projected to reach $378.90M by 2025, growing at a CAGR of 8.0%.

Asia Pacific market size reached $136.74M in 2016 and is projected to reach $297.31M by 2025, growing at a CAGR of 9.0%.
Europe market size reached $202.67M in 2016 and is projected to reach $420.77M by 2025, growing at a CAGR of 8.5%.
South America market size reached $47.13M in 2016 and is projected to reach $77.44M by 2025, growing at a CAGR of 5.7%.

Subscribe to Wantstats

Unlock premium reports, insights, blogs, charts and more.

View Subscription Plans

Research Methodology

Primary Cells Market — How We Researched This Market

This report applies a rigorous multi-stage research process combining primary interviews, secondary data sources, and bottom-up market modelling to ensure accuracy and completeness across all segments and geographies.

Base Year
2018
Historical Period
2016 – 2017
Forecast Period
2019 – 2025
Primary Interviews
150+

Research Process

Historical data (2016–2018) and forecast period (2018–2025)

Problem Definition

Market scoping
Objective setting
Framework design

Secondary Research

Literature review
Data mining
Trend analysis

Primary Research

Expert interviews
Field visits
Surveys

Data Analysis

Quantitative modeling
Statistical testing
Validation

Insights & Reporting

Synthesis
Recommendations
Visualization

Research Depth

Our research process spans primary interviews with industry stakeholders combined with comprehensive secondary data analysis, validated through triangulation across multiple independent sources.

Historical vs. Forecast Data

Historical (observed)

Forecast (modelled)

Subscribe to Wantstats

Unlock premium reports, insights, blogs, charts and more.

View Subscription Plans

Competitive Landscape & Porter's Five Forces

Primary Cells Market — Competitive Analysis

The global primary cells market is a very lucrative, attractive, and profitable market, both for existing players as well as new entrants. At the same time, intense rivalry among existing competitors has been observed. Our analysis revealed that market players have adopted different strategies to increase their business and position in the global primary cells market.

In recent years, strategic movements made by major players were product launches, acquisitions, and strategic agreements, which have been used as market penetration strategies and to reduce competition. The major players in the global primary cells market are Lonza, STEMCELL Technologies Inc, Thermo Fisher Scientific Inc., Merck KGaA, Cell Biologics, Inc., and others.

Companies are now entering into collaborations, product launches, and expansions to neutralize growing competition from customers, competitors, and to tackle the changing market dynamics.

There are numerous players operating in this market all over the globe. Most of these players exist in the American and European regions. There are a lot of large and small market players available in the market which provide a wide range of products.

Lonza, STEMCELL Technologies Inc, Thermo Fisher Scientific Inc., Merck KGaA, Cell Biologics, Inc., and others are the major players in the global primary cells market, contributing a major share of the total global market.

Threat of New Entrants

The threat of new entrants is moderate in the global primary cell market due to the initial investment cost and the presence of major players. Any company trying to enter the market is required to accept and abide by the mandatory regulatory standards. This market is characterized by different types of products, a reasonable degree of brand loyalty, where establishing a brand name is difficult for new entrants. The growing healthcare industry, market profitability, and research activity encourage new players to enter the market. There is a stronghold of the big companies in this market, which can make the entry of the new players challenging. Thus, the threat of new entrants in the market is moderate in the global primary cell market.

Bargaining Power of Suppliers

In the global primary cell, the suppliers are healthcare companies that manufacture reagents, culture media, and cell cultures. The existing key companies capture a significant share of the market and have the capability of influencing the cost of the products. Another factor affecting the bargaining power of suppliers is the number of buyers and suppliers in the market, as there is large number of buyers in the market, which can increase the demand for the product and supports the bargaining power of suppliers. But the low dependency of buyers on suppliers and the presence of alternative products in the market decreases the bargaining power of suppliers. By considering the above-mentioned factors the bargaining power of suppliers is moderate in the primary cell market.

Threat of Substitutes

The threat of substitutes in the global primary cell market is moderate. The presence of substitutes, such as cell lines, can offer a roughly similar application. The availability of alternative products in the market may increase the threat of substitutes in the primary cell market.

Bargaining Power of Buyers

Pharmaceutical & biotech companies, research centers, and academies are the primary buyers in the market. The presence of a large number of buyers owing to the increasing use of primary cells in the healthcare industry in new drug development supports the bargaining power of buyers. Also, some buyers are price and brand sensitive and might prefer particular products from certain companies, thereby moderately affecting their bargaining power in the market. Thus, the bargaining power of buyers is moderate.

Intensity of Rivalry

The degree of competition in the global primary cell market is moderate to high. The moderate degree of product differentiation among existing players increases the intensity of rivalry in the market. Companies involved in the primary cell market are trying to develop different types of products to grow their business. To overcome the competition, players are engaged in developing a process to lower their manufacturing costs. Moreover, the players are also developing advanced manufacturing techniques for differentiating their product from their rivals.

Quantitative Analysis

Regional Breakdown

Regional market breakdown for Primary Cells Market.

Regional Market Size (USD Mn)

Market estimates by geography (2025)

USD Mn

InsightEurope leads with $420.77M by 2025, while Asia Pacific is projected to grow fastest at a 9.0% CAGR.

Subscribe to Wantstats

Unlock premium reports, insights, blogs, charts and more.

View Subscription Plans

Regional Market Data

REGION	2016	2018	2025	CAGR	SHARE
Middle East and Africa	$34.18M	$46.73M	$59.24M	6.3%	5%
North America	$189.72M	$274.39M	$378.90M	8.0%	31%
Asia Pacific	$136.74M	$207.67M	$297.31M	9.0%	24%
Europe	$202.67M	$300.00M	$420.77M	8.5%	34%
South America	$47.13M	$61.40M	$77.44M	5.7%	6%
Total	$610.44M	$890.19M	$1.23B	8.1%	100%

Subscribe to Wantstats

Unlock premium reports, insights, blogs, charts and more.

View Subscription Plans

Segment Revenue (2025)

Human Primary Cells

Animal Primary Cells

00.250.50.751

Human Primary Cells71%
Animal Primary Cells29%

Total Market Size

$1.23B

Market by Segment (2025)

APPLICATION	REVENUE ($B)	GROWTH RATE	MARKET PENETRATION
Human Primary Cells	$872.71M	8.0%	71%
Animal Primary Cells	$360.95M	8.5%	29%

* Revenue projections based on 2025 estimates. Growth rates represent CAGR 2024–2030. Market penetration indicates current adoption rate within addressable market segments.

Subscribe to Wantstats

Unlock premium reports, insights, blogs, charts and more.

View Subscription Plans

Empower your Business
with Insights

Save over 20% on
Annual Subscription

Subscribe now

Book a demo

See plans for professionals or small and medium businesses.

Analytics

Primary Cells Market — Key Findings

Analytical insights on Primary Cells Market covering market dynamics, competitive landscape, and strategic outlook.

Key Analytical Findings

The Primary Cells Market market is projected to reach $1.23B by 2025, growing at 8.1% CAGR. The Human Primary Cells segment holds the largest share.

Market Dynamics

Primary human cells are isolated directly from normal human tissue or blood cells via the enzymatic or mechanical method. Primary cells retain their fundamental cellular functions. Hence, their use in cell-based research programs is increasing significantly.

Numerous factors such as rapid growth in the biotechnology and biopharmaceutical industries, growing cancer research, rising adoption of primary cells over cell lines, increasing demand for monoclonal antibodies, and rising healthcare expenditure are anticipated to drive the growth of the market during the forecast period. Additionally, the growing research on personalized therapies and stem cells is likely to contribute to market growth. However, the high cost of advanced primary cells and risk of contamination may hamper the growth of the market. The increasing preference of primary cells in research and development to develop new drug acts as opportunities for the growth of the primary cell market.

Market Drivers

Cancer is one of the major causes of death across the globe and is responsible for a large number of deaths. Different pharmaceutical companies and research institutes are involved in developing cancer treatment drugs using cell culture. The increasing prevalence of cancer across the globe is promoting the demand for research activities to develop new drugs. According to the National Cancer Institute in 2018, around 1,735,350 cases of cancer were diagnosed in the US alone.

Additionally, Cancer Research UK reported that in 2018 the new cases of cancer were reported to be 17 million across the world. The increasing number of populations suffering from cancer increases the demand for new research activities to develop new drugs, which ultimately increases the demand for products such as primary cell culture. For instance, the National Cancer Institute conducts different research on cancer biology, cancer genomics, and causes of cancer using primary cell culture. Additionally, there are different major and small manufacturers and suppliers such as Merck KGaA and PromoCell GmbH, who provide primary cells for cancer research.

In research activity, primary cells are used for drug screening and to study the effect of drugs on human cells. During cancer research the primary cells are exposed to different chemicals, radiations, and can be infected with viruses to make them cancerous. These cells can be used to study the cause of cancer, mechanism, and transformed signaling pathways. They are also used to study the adverse effects of cancer treatments such as chemotherapy and irradiation on normal cells. The increasing prevalence of cancer and research activities to develop new drugs drives the market growth of primary cells.

Market Opportunities

Research and development activities are growing across the globe due to the increasing number of pharmaceutical and biotech manufacturing units. The primary cell is used in drug screening at the clinical stage, before launching the drug into the market. The increasing focus on genomic research, personalized medicines, and growing research on cancer treatment act as an opportunity for market growth. Increasing use of primary cells in 3D cell culture technology to study cell morphology, cancer cells, and new drug development acts as an opportunity to grow the market in the future.

The increasing number of biobanks to store different types of cells collected from the donor has supported the primary cell market by increasing the availability of human primary cell samples used in research. The increasing number of cell banks across the world drives market growth. The cryopreservation method is also an efficient technique through which the cells can be stored for longer period with similar cell property and can be used whenever required.

Also, increasing funding by the government for research and development activity in pharmaceutical sector supports market growth. For instance, in 2014 governments of Organization for Economic Cooperation and Development (OECD) countries accounted about USD 51 billion on health-related research and development. Thus, improving research and development (R&D) and increasing number of biobanks are expected to be the greatest opportunities for the global primary cell market.

Market Restraints

Contamination is the most common problem while working in laboratories using cell culture. Mycoplasma, fungi, yeast, bacteria, chemicals, and laboratory instruments are different sources of contamination in labs, whereas the microbial contamination occurs through poor handling of culture, using nonsterile equipment and instruments. In addition, laboratory facilities such as laminar airflow and humidified incubators are sources for contamination while handling primary cells.

Other factors, such as limited lifetime of primary cells compared to immortalized cell lines may affect the demand for these cells. Additionally, another limitation of primary cells is the procedure to isolate the cells using different chemicals and enzymes. These procedures affect cellular products and damages the integrity of the cell membrane that may affect the quality of the primary cell. The change in the quality of cell hampers the demand for products from researchers.

Strategic Outlook and Future Directions

Near-term growth will likely concentrate in modular bioreactor lines and closed-system media workflows that shorten validation cycles while preserving batch traceability.

Partnerships between CDMOs and instrumentation vendors should accelerate standard datasets for comparability across sites, improving forecasting models used in capacity planning.

Longer horizon, organoid and microphysiological adoption may reshape segment mix; teams that invest early in assay interoperability and cloud QC hooks are better positioned to capture upside without fragmenting their analytics stack.

Market Value by Segment (2025)

Value (USD Mn)

Human Primary Cells

Animal Primary Cells

Companies

Key companies profiled in Primary Cells Market

Profiles of 106 companies operating in the Primary Cells Market market, including revenue, employee count, and market positioning where available.

Region

Industry

Founded Year

Showing 106 of 106 companies

Lonza Grou

Lonza Group AG

Healthcare

Company Headquarters: Basel, Switzerland Founded: 1897 Workforce: ~15,375 Company Working: Lonza is engaged in the manufacturing and supply of oilfield biocides as well as pharmaceutical, healthcare, and life science products. It operates through the pharma & biotech, specialty ingredients, and corporate segments. The specialty ingredients segment consists of two divisions, consumer health and consumer resources and protection. The pharma & biotech segment comprises the development and manufacturing of customized active pharmaceutical ingredients and biopharmaceuticals as well as formulation services and delivery systems. The corporate segment includes corporate functions, such as finance and accounting, legal, communication, information technology, and human resources.

STEMCELL Technologies Inc

Healthcare

STEMCELL Technologies Inc. is a biotech company that offers cell culture and cell separation media used in the research field. These mediums are used in hematology, immunology, neuroscience, stem cell, epithelial cell biology, and mesenchymal cell. STEMCELL Technologies Inc. delivers around 2,500 products to more than 80 countries globally. STEMCELL is the largest biotechnology company in Canada and has offices in eight countries, including the US, UK, Germany, France, Australia, Singapore, and China. Along with the cell culture medium, the company specializes in stem cell detection kits, software, training courses, contract services, and proficiency testing.

United States, North America

PromoCell

Healthcare

PromoCell is a manufacturer of cell culture products and offers a collection of adult stem cells, as well as blood cells from normal human bone marrow, umbilical cord tissue, placenta, adipose tissue, peripheral blood, and cord blood. The company’ s product portfolio also includes high-quality media for these cell types, in addition to optimized differentiation media systems.

United States, North America

Axol Biosc

Axol Bioscience Ltd

Healthcare

Axol Bioscience Ltd manufactures human cell products and critical reagents such as media and growth supplements. The company expertise in reprogramming cells to iPSCs and then differentiating to various cell types. They supply differentiated cells obtained from healthy donors and patients of certain disease backgrounds. In addition to this, they also take primary extract cells provided by customers and then reprogram and differentiate. The company also offers optimized media, coating solutions, and other reagents. Their in-house R&D team works to improve existing media and reagents as well as innovate new products for human cell culture.

United States, North America

American T

American Type Culture Collection (ATCC)

Healthcare

American Type Culture Collection (ATCC) is a global biological materials resource and standards organization. It offers a broad range of products and services manufactured under ISO certification and accreditation. The institutes’ offerings include human & animal cell lines, continuous primary, immortalized, and stem cells; cell and microbial derivatives; culture media and reagents; molecular genomic tools; microorganisms; and biological products. ATCC researches to improve the preservation, propagation, classification, and characterization of cultures and to develop new & enhanced culture products through in-house efforts & collaborative alliances

United States, North America

AllCells

Healthcare

AllCells provides high quality human primary blood and marrow-based cells from the last 21 years. The company's line of business includes the production of bacterial and virus vaccines, toxoids, and analogous products. It is a leading biotechnology company dedicated to providing researchers and biomanufacturing organizations with high-quality primary cells that enable preclinical development, drug discovery, and manufacturing of cell therapies. The company maintains a large repository of donor profiles that can be qualified for various biomedical applications. AllCells is based in Alameda, California, USA

United States, North America

Page 1 of 18

…

Go to page

About the Author

Healthcare Research Team

Healthcare

Our healthcare desk at Wantstats is staffed by a mix of clinical-market analysts and a senior researcher who track drug approvals, device launches, and provider economics as they happen — not just at reporting time. Every figure in this report is checked against primary interviews, regulatory filings, and our own proprietary datasets before it goes to print.

Similar Reports

View all

HealthcareJul 31, 2026

Stoma Ostomy Care Market

HealthcareJul 31, 2026

Ready-to-eat Popcorn Market

HealthcareJul 31, 2026

Organoids and Spheroids Market

Powering the world's best teams.
From next-gen startups to established enterprises.

What our clients say

Trusted by forward-thinking businesses
for data-driven intelligence

Noah Malgeri

Co-Founder, Mojave Rail Fabrication Limited

This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job.

Michael Robert

Manager, JavolVision

Thanks, I am so happy that we worked together. Maybe we still can work together in the future.

Joseph Aguayo

Sales Operations & Pricing Manager, Intel

Thanks. It's been a pleasure working with you, please use me as reference with any other Intel employees.

Bong Lau

Sales Leader, Bamberg

We bought your "2025 report" in 2020. Everything is fine and very good.

Peter Groot Koerkamp

Account and Business Manager, EFS-Holland BV

Thanks for sending the report it gives us a good global view of the Betaïne market.

Younghwan Choi

Senior Retail Manager, LG Chem

We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.

Mark Irwin

Management Consultant, Level 21

I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.

Rob Kooiker

Group Product Manager HVAC & Fire Protection GMA, Rockwool

I have been reading the first document or the study, the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!

Jason Lee

R&D Director, Seojin

Thanks for your great support. Appreciate it. Well received report. It helps us to understand market well. We're planning other area of survey in the future, let's keep in touch.

Akif Moroglu

Strategy & Business Development Director, Dogan Holding

We got the report in time, we really thank you for your support in this process. I also thank to all of your team as they did a great job.

Noah Malgeri

Co-Founder, Mojave Rail Fabrication Limited

This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job.

Michael Robert

Manager, JavolVision

Thanks, I am so happy that we worked together. Maybe we still can work together in the future.

Joseph Aguayo

Sales Operations & Pricing Manager, Intel

Thanks. It's been a pleasure working with you, please use me as reference with any other Intel employees.

Bong Lau

Sales Leader, Bamberg

We bought your "2025 report" in 2020. Everything is fine and very good.

Peter Groot Koerkamp

Account and Business Manager, EFS-Holland BV

Thanks for sending the report it gives us a good global view of the Betaïne market.

Younghwan Choi

Senior Retail Manager, LG Chem

We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.

Mark Irwin

Management Consultant, Level 21

I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.

Rob Kooiker

Group Product Manager HVAC & Fire Protection GMA, Rockwool

I have been reading the first document or the study, the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!

Jason Lee

R&D Director, Seojin

Thanks for your great support. Appreciate it. Well received report. It helps us to understand market well. We're planning other area of survey in the future, let's keep in touch.

Akif Moroglu

Strategy & Business Development Director, Dogan Holding

We got the report in time, we really thank you for your support in this process. I also thank to all of your team as they did a great job.

Primary Cells Market

Primary Cells Market Research Report: Size, Share, Trend Analysis Type (Human Primary Cells, Animal Primary Cells), Source (Hematopoietic Cells, Skin Cells, Gastrointestinal Cells, Liver Cells, Lung Cells, Skeletal and Muscle Cells), End User (Pharmaceutical and Biotechnology Companies, Research Institutes) and By Region (Middle East and Africa, North America, Asia Pacific, Europe, South America) - Growth Outlook & Industry Forecast To 2025

Starting from

$4,950

Primary Cells Market

Key Insight

Market Performance Trend

Market Scope & Coverage

What this report covers

Primary Cells Market — Growth Trajectory

Market Size Trend (USD Mn)

Market Dimensions

How this market is segmented

Geographic Analysis

Regional market breakdown

Problem Definition

Secondary Research

Primary Research

Data Analysis

Insights & Reporting

Research Depth

Historical vs. Forecast Data

Competitive Landscape & Porter's Five Forces

Primary Cells Market — Competitive Analysis

Regional Market Data

Segment Revenue (2025)

Segment Market Share

Market by Segment (2025)

Save over 20% onAnnual Subscription

Key Analytical Findings

Market Dynamics

Market Drivers

Market Opportunities

Market Restraints

Strategic Outlook and Future Directions

Market Value by Segment (2025)

About the Author

Healthcare Research Team

Market Performance Trend

Primary Cells Market — Growth Trajectory

Market Size Trend (USD Mn)

Market Dimensions

How this market is segmented

Geographic Analysis

Regional market breakdown

Problem Definition

Secondary Research

Primary Research

Data Analysis

Insights & Reporting

Research Depth

Historical vs. Forecast Data

Competitive Landscape & Porter's Five Forces

Primary Cells Market — Competitive Analysis

Regional Market Data

Segment Revenue (2025)

Segment Market Share

Market by Segment (2025)

Save over 20% onAnnual Subscription

Key Analytical Findings

Market Dynamics

Market Drivers

Market Opportunities

Market Restraints

Strategic Outlook and Future Directions

Market Value by Segment (2025)

About the Author

Healthcare Research Team

Save over 20% on
Annual Subscription

Save over 20% on
Annual Subscription